Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16242623 | 0.81 | EPHX2 (0.34) | KMT2AMAPTMAPK1LMNAALDH1A1 | |
| SCHEMBL30184983 | 0.76 | EPHX2 (0.40) | KMT2AMAPTMAPK1LMNAALDH1A1 | |
| SCHEMBL23358282 | 0.76 | HSD17B10 (0.36) | ALDH1A1EPHX2GAA | |
| SCHEMBL28720361 | 0.70 | GAA (0.36) | KMT2AMAPTMAPK1LMNAALDH1A1 | |
| SCHEMBL27171589 | 0.70 | GAA (0.36) | KMT2AMAPTMAPK1LMNAALDH1A1 | |
| SCHEMBL3205986 | 0.68 | EPHX2 (0.34) | KMT2AMAPTMAPK1LMNAALDH1A1 | |
| SCHEMBL15133406 | 0.65 | KMT2A (0.32) | KMT2AMAPTMAPK1LMNAALDH1A1 | |
| SCHEMBL9152767 | 0.65 | SLC6A3 (0.38) | MAPT | |
| Dexborneol SCHEMBL8072615 | 0.64 | MAPT (0.39) | KMT2AMAPTMAPK1LMNAALDH1A1 | |
| Dexborneol SCHEMBL8072618 | 0.64 | MAPT (0.39) | KMT2AMAPTMAPK1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1480600-A4 | METHOD AND COMPOSITION FOR DIMINISHING LOSS OF COLOR IN FLAVORS AND FRAGRANCES | CITRUS AND ALLIED ESSENCES LTD (US) | 2007-10-31 | — | — | EP | claimed |
| EP-1581058-A4 | METHOD AND COMPOSITION FOR THE PREVENTION OF THE AUTO-OXIDATION OF FLAVORS AND FRAGRANCES | CITRUS AND ALLIED ESSENCES LTD (US) | 2006-11-29 | — | — | EP | claimed |
| EP-1581058-A1 | METHOD AND COMPOSITION FOR THE PREVENTION OF THE AUTO-OXIDATION OF FLAVORS AND FRAGRANCES | Citrus and Allied Essences, Ltd. (US) | 2005-10-05 | — | — | EP | claimed |
| EP-1480600-A1 | METHOD AND COMPOSITION FOR DIMINISHING LOSS OF COLOR IN FLAVORS AND FRAGRANCES | Citrus and Allied Essences, Ltd. (US) | 2004-12-01 | — | — | EP | claimed |
| WO-2004039160-A1 | METHOD AND COMPOSITION FOR THE PREVENTION OF THE AUTO-OXIDATION OF FLAVORS AND FRAGRANCES | CITRUS AND ALLIED ESSENCES, LTD. (US) | 2004-05-13 | — | — | WO | claimed |
| WO-2003066006-A1 | METHOD AND COMPOSITION FOR DIMINISHING LOSS OF COLOR IN FLAVORS AND FRAGRANCES | CITRUS AND ALLIED ESSENCES, LTD. (US) | 2003-08-14 | — | — | WO | claimed |
| US-20030147972-A1 | Method and composition for diminishing loss of color in flavors and fragrances | CITRUS AND ALLIED ESSENCES, LTD. | 2003-08-07 | — | — | US | claimed |
| US-20030078186-A1 | Method and composition for the prevention of the auto-oxidation of flavors and fragrances | CITRUS AND ALLIED ESSENCES, LTD. | 2003-04-24 | — | — | US | claimed |
| EP-0596493-B1 | Fragrant peracetic acid-containing oxidizing composition | NIPPON PEROXIDE CO LTD (JP) | 1999-02-03 | — | — | EP | claimed |
| US-5451346-A | Fragrant peracetic acid-containing oxidizing composition | INABATA KORYO CO., LTD. (JP) | 1995-09-19 | — | — | US | claimed |
| EP-0596493-A1 | Fragrant peracetic acid-containing oxidizing composition | NIPPON PEROXIDE CO., LTD. (JP) | 1994-05-11 | — | — | EP | claimed |
| US-12605330-B2 | Screening method for offensive odor-suppressing material | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12533310-B2 | Fragrance or flavor composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2026-01-27 | — | — | US | disclosed |
| EP-4052762-B1 | SCREENING METHOD FOR OFFENSIVE ODOR SUPPRESSING MATERIAL | TAKASAGO PERFUMERY CO LTD (JP) | 2025-08-27 | — | — | EP | disclosed |
| US-20220411884-A1 | SCREENING METHOD FOR OFFENSIVE ODOR-SUPPRESSING MATERIAL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-12-29 | — | — | US | disclosed |
| US-6194468-B1 | INCLUDING P-MENTHANE-3,8-DIOL, WHICH HAS THE ACTION OF PROMOTING PERCUTANEOUS ABSORPTION, AND AT LEAST ONE BLOOD CIRCULATION PROMOTER TO STIMULATE HAIR GROWTH; DOES NOT CAUSE SIDE EFFECTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-02-27 | — | — | US | disclosed |
| EP-0934741-A1 | Hair growth stimulants | Takasago International Corporation (JP) | 1999-08-11 | — | — | EP | disclosed |
| EP-0596493-B1 | Fragrant peracetic acid-containing oxidizing composition | NIPPON PEROXIDE CO LTD (JP) | 1999-02-03 | — | — | EP | disclosed |
| US-5451346-A | Fragrant peracetic acid-containing oxidizing composition | INABATA KORYO CO., LTD. (JP) | 1995-09-19 | — | — | US | disclosed |
| EP-0596493-A1 | Fragrant peracetic acid-containing oxidizing composition | NIPPON PEROXIDE CO., LTD. (JP) | 1994-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12533310-B2 | Fragrance or flavor composition | OR10J3, OR51E2, ORMDL3 | KMT2A 3822/4885MAPT 4570/4885MAPK1 1898/4885 |
| US-12605330-B2 | Screening method for offensive odor-suppressing material | OR51E2, OR10J3, OXER1 | KMT2A 3832/4885MAPT 4741/4885MAPK1 1900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.